Enog, Hannan .

HRN: 26-78-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/04/2025
CEFUROXIME 1.5GM (VIAL)
03/04/2025
03/04/2025
IV
1.5 G
Loading Dose
For CS
Waiting Final Action 
03/04/2025
CEFUROXIME 1.5GM (VIAL)
03/04/2025
03/05/2025
IVT
1.5gms
Q12
S/P CS
Waiting Final Action 
03/04/2025
METRONIDAZOLE 500MG (TAB)
03/04/2025
03/05/2025
IVT
500mg
Q8
S/p Primary LTCS
Waiting Final Action 
03/06/2025
CEFUROXIME 500MG (TAB)
03/06/2025
03/13/2025
PO
500 MG
BID
NKA
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: